Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chronic Care Quality: Industry Engages Lawmakers, As CMS Floats Core Measures

This article was originally published in The Gray Sheet

Executive Summary

Industry groups tell a Senate committee that federal health care quality measures for patients with chronic conditions should reduce burdens on providers, and also address underuse – as well as overuse – of medical technologies. Meanwhile, CMS and private insurers released their first set of core quality measures as a basis for payments to ACOs and other fee-for-service alternatives.

You may also be interested in...



AdvaMed: Medtech Needs Voice in Value-Based Health-Care Models

New frameworks issued by the trade group attempt to press the industry's view of "value" and how it should be measured for medical devices.

Senate Draft Chronic-Care Bill Seeks To Expand Telehealth Opportunities

The US Senate Finance Committee circulated a discussion draft of a chronic-care bill Oct. 27 that would promote telehealth and home-use devices. The bill would allow reimbursement for providers to use technology to monitor patients with chronic diseases through telehealth options in Medicare Advantage plans and accountable-care organizations.

Companies Support Telehealth Reforms – But Seek Demo Projects First

Responding to a chronic care reform effort by the Senate Finance Committee, AdvaMed, device firms and several medical groups asked for demo projects and waivers to appropriately expand the use of telehealth services.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034973

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel